Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1996
12/19/1996WO1996040718A1 Expression of lipoproteins
12/19/1996WO1996040717A1 High-affinity nucleic acid ligands of cytokines
12/19/1996WO1996040715A1 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes
12/19/1996WO1996040711A1 Cross-linking oligonucleotides
12/19/1996WO1996040709A1 Pna-dna chimeras and pna synthons for their preparation
12/19/1996WO1996040707A1 Water-soluble adenosine kinase inhibitors
12/19/1996WO1996040706A1 Orally active adenosine kinase inhibitors
12/19/1996WO1996040705A1 C-4' modified adenosine kinase inhibitors
12/19/1996WO1996040703A1 High affinity nucleic acid ligands to lectins
12/19/1996WO1996040695A1 Membrane-permeant second messengers
12/19/1996WO1996040689A1 Cytotoxic macrolides
12/19/1996WO1996040688A1 Triterpenes
12/19/1996WO1996040687A1 (r)-(z)-1-azabicyclo[2.2.1]heptan-3-one,o-[3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent
12/19/1996WO1996040686A1 Heterocyclic substituted cyclopentane compounds
12/19/1996WO1996040683A1 Novel derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
12/19/1996WO1996040682A1 3-pyridyloxyalkyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
12/19/1996WO1996040681A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists
12/19/1996WO1996040679A1 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
12/19/1996WO1996040672A1 Combinatorial libraries having aminodiol monomer subunits
12/19/1996WO1996040671A1 Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
12/19/1996WO1996040670A1 2-iminochromene derivatives as inhibitors of protein tyrosine kinase
12/19/1996WO1996040669A1 Retinoids and methods of use of same
12/19/1996WO1996040668A2 Small molecule inhibition of rna/ligand binding
12/19/1996WO1996040665A1 N-substituted piperazine nonoates
12/19/1996WO1996040663A1 Di- and tri-aminoguanidines and their use to inhibit the advanced glycosylation of proteins
12/19/1996WO1996040660A1 Certain substituted benzylamine derivatives: a new class of neuropeptide y1 specific ligands
12/19/1996WO1996040659A1 N-hydroxyureas as antiinflammatory agents
12/19/1996WO1996040657A1 Inhibitors of phospholipase a¿2?
12/19/1996WO1996040656A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996WO1996040655A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3y l)-3-amides
12/19/1996WO1996040654A1 Novel n-(2,4-dioxo-2,3,4,5-tetrahydro-1h-1,5-benzodiazepin-3yl)-3-amides
12/19/1996WO1996040653A1 Novel n-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1h-benzo[b][1,4]diazepin-3-yl)-acetamides
12/19/1996WO1996040652A1 Method for preparing n-monosubstituted and n,n'-disubstituted unsymmetrical cyclic ureas
12/19/1996WO1996040651A1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996WO1996040650A1 Cyclic amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/19/1996WO1996040649A1 Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists
12/19/1996WO1996040648A1 Quinazolines and pharmaceutical compositions
12/19/1996WO1996040647A1 α-(1,3-DICARBONYLENOL ETHER) METHYL KETONES AS CYSTEINE PROTEASE INHIBITORS
12/19/1996WO1996040646A1 Dihydrophthalazine antagonists of excitatory amino acid receptors
12/19/1996WO1996040645A1 2-substituted benzimidazole derivatives as inhibitors of smooth muscle cell proliferation
12/19/1996WO1996040644A1 2-substituted benzimidazole derivatives as smooth muscle cell proliferation inhibitors
12/19/1996WO1996040640A1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION
12/19/1996WO1996040639A1 Benzenesulfonamide derivatives used as bradykinine antagonists
12/19/1996WO1996040638A1 Heteroaryl diol acids as leukotriene antagonists
12/19/1996WO1996040637A1 Stable reagents for the preparation of radiopharmaceuticals
12/19/1996WO1996040636A1 Catechol diethers derivatives useful as pharmaceutical agents
12/19/1996WO1996040634A1 Pyrrole derivatives and medicinal composition
12/19/1996WO1996040633A1 Small molecule inhibitors of rotamase enzyme activity
12/19/1996WO1996040628A1 Semicarbazones having cns activity and pharmaceutical preparations containing same
12/19/1996WO1996040627A2 Thiocationic lipids, pharmaceutical compositions and methods of use thereof
12/19/1996WO1996040620A1 Chalcone retinoids and methods of use of same
12/19/1996WO1996040355A1 Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen
12/19/1996WO1996040290A1 Immunological combination compositions and methods
12/19/1996WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy
12/19/1996WO1996040273A2 Conjugates of ferrites and oligonucleotides, which bond specifically to certain target structures
12/19/1996WO1996040266A1 Method of treatment for asthma
12/19/1996WO1996040265A1 Stabilization of polynucleotide complexes
12/19/1996WO1996040262A2 Process for preparing encapsulated water soluble beta-carotene
12/19/1996WO1996040258A2 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996WO1996040257A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996WO1996040255A2 Method to treat cardiofibrosis with a combination therapy of an angiotensin ii antagonist and an epoxy-steroidal aldosterone antagonist
12/19/1996WO1996040253A2 Rna photocleavage using texaphyrins
12/19/1996WO1996040250A2 Platelet-specific chimeric immunoglobulin and methods of use therefor
12/19/1996WO1996040237A1 Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep
12/19/1996WO1996040228A1 Compositions exhibiting adp-ribosyltransferase activity and methods for the preparation and use thereof
12/19/1996WO1996040226A1 Method for screening potential anti-obesity agents and agent
12/19/1996WO1996040223A1 Oxidant scavengers
12/19/1996WO1996040222A1 Hemodilution facilitated by monitoring oxygenation status
12/19/1996WO1996040219A1 Inhibin compositions and methods of enhancing production performance
12/19/1996WO1996040210A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996WO1996040206A1 Novel kappa receptor selective opioid peptides
12/19/1996WO1996040199A1 Methods of inhibiting phagocytosis
12/19/1996WO1996040194A1 Stable formulations of mhc-peptide complexes
12/19/1996WO1996040192A1 Use of essential oils to increase bioavailability of oral pharmaceutical compounds
12/19/1996WO1996040191A1 The treatment of hiv and other viral infections using combinatory therapy
12/19/1996WO1996040186A1 Relaxin-like factor and methods and uses thereof
12/19/1996WO1996040184A1 New cryptophycins from synthesis
12/19/1996WO1996040183A1 OCULAR THERAPY IN SJÖGREN'S SYNDROME USING TOPICALLY APPLIED ANDROGENS OR TGF-$g(b)
12/19/1996WO1996040181A1 Processed ginseng having enhanced pharmacological effect
12/19/1996WO1996040179A1 Method of improving animal health
12/19/1996WO1996040169A1 Bacterial inhibition with an oligosaccharide compound
12/19/1996WO1996040168A2 Use of hydroxyethyl starch to prevent post surgical adhesion and as an intracavity carrier device
12/19/1996WO1996040167A1 Augmented atp production
12/19/1996WO1996040166A1 Nucleotide analogues for topical treatment of proliferative disease of the skin
12/19/1996WO1996040165A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides
12/19/1996WO1996040164A1 Nucleosides with anti-hepatitis b virus activity
12/19/1996WO1996040162A1 Method of treatment for lung diseases using antisense oligonucleotides
12/19/1996WO1996040161A1 Ether derivatives of pseudopterosin
12/19/1996WO1996040160A1 Use of pseudopterosins for promoting wound healing
12/19/1996WO1996040159A1 Capped synthetic rna, analogs, and aptamers
12/19/1996WO1996040158A1 Method of treating chronic progressive vascular diseases
12/19/1996WO1996040157A1 USE OF ANTISENSE OLIGONUCLEOTIDES TO IL-6 RECEPTOR mRNA TO INHIBIT CELLULAR PROLIFERATION
12/19/1996WO1996040155A1 Use of specific acpa derivative (npc-17742) for the treatment of ischemia
12/19/1996WO1996040154A1 Use of vitamin d4 derivatives for treating skin disorders
12/19/1996WO1996040153A1 Use of vitamin d4 derivatives for treating cancer
12/19/1996WO1996040152A1 Dehydroepiandrosterone derivatives for preventing progressive tissue necrosis reperfusion injury, bacterial translocation and adult respiratory distress syndrome
12/19/1996WO1996040151A1 Use of squalamine for the manufacture of a medicament for inhibiting nhe
12/19/1996WO1996040150A1 Treatment and prevention of prostatic disease
12/19/1996WO1996040149A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
12/19/1996WO1996040148A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
1 ... 6845 6846 6847 6848 6849 6850 6851 6852 6853 6854 6855 6856 6857 6858 6859 6860 6861 6862 6863 6864 6865 ... 7860